References

NSTOP-Pishin-Checking-Finger-Marking-of-a-Nomadic-Child

  1. Effect of Inactivated Poliovirus Vaccine Campaigns, Pakistan, 2014-2017.external icon
    November 2018
  2. Introduction of inactivated poliovirus vaccine in the Philippines: Effect on health care provider and infant caregiver attitudes and practices.external icon
    November 2018
  3. Does Simultaneous Administration of Bivalent (Types 1 and 3) Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine Induce Mucosal Cross-immunity to Poliovirus Type 2?external icon
    October 2018
  4. Immune Priming and Long-term Persistence of Memory B Cells After Inactivated Poliovirus Vaccine in Macaque Models: Support for at least 2 Doses.external icon
    October 2018
  5. Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians’ perspectives in the endgame plan for polio eradication.external icon
    October 2018
  6. Trends in Poliovirus Seroprevalence in Kano State, Northern Nigeria.external icon
    October 2018
  7. Feasibility of jet injector use during inactivated poliovirus vaccine house-to-house vaccination campaigns.external icon
    August 2018
  8. Modeling Poliovirus Transmission in Pakistan and Afghanistan to Inform Vaccination Strategies in Undervaccinated Subpopulations.external icon
    August 2018
  9. Polio priority countries and the 2018 Hajj: Leveraging an opportunity.external icon
    August 2018
  10. Type 2 Poliovirus Detection after Global Withdrawal of Trivalent Oral Vaccine.external icon
    August 2018
  11. Notes from the Field: Widespread Transmission of Circulating Vaccine-Derived Poliovirus Identified by Environmental Surveillance and Immunization Response – Horn of Africa, 2017-2018.external icon
    July 2018
  12. Immunogenicity of type 2 monovalent oral and inactivated poliovirus vaccines for type 2 poliovirus outbreak response: an open-label, randomized controlled trial.external icon
    June 2018
  13. Progress Toward Polio Eradication – Worldwide, January 2016-March 2018.external icon
    May 2018
  14. Cuba’s Scientific Contributions to Global Polio Eradicationexternal icon.
    April 2018
  15. Assessment of poliovirus antibody seroprevalence in high risk areas for vaccine derived poliovirus transmission in Madagascar.external icon
    March 2018
  16. Assessing the potency and immunogenicity of inactivated poliovirus vaccine after exposure to freezing temperatures.external icon
    March 2018
  17. Progress Toward Poliomyelitis Eradication – Nigeria, January-December 2017.external icon
    March 2018
  18. Seroprevalence of anti-polio antibodies in children from polio high risk area of Afghanistan: A cross sectional survey 2017external icon
    March 2018
  19. Strengthening Acute Flaccid Paralysis Surveillance Through the Village Polio Volunteers Program in Somaliaexternal icon
    March 2018
  20. Using Predictive Evaluation to Design, Evaluate, and Improve Training for Polio Volunteers.external icon
    March 2018
  21. Vaccine-Derived Poliovirus Outbreaks and Events – Three Provinces, Democratic Republic of the Congo, 2017.external icon
    March 2018
  22. Evaluation of vaccine derived poliovirus type 2 outbreak response options: A randomized controlled trial, Karachi, Pakistan.external icon
    February 2018
  23. Global Polio Eradication – Way Aheadexternal icon
    January 2018
  24. Unraveling the Mucosal Immunity of Inactivated Poliovirus Vaccineexternal icon
    January 2018
Page last reviewed: October 24, 2019
Content source: Global Immunization